Gérard M London

Iron Therapy, Advanced Oxidation Protein Products, and Carotid Artery Intima-Media Thickness in End-Stage Renal Disease

G. London, A. Guérin, S. Marchais, 2002, Circulation.

Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency.

G. London, A. Guérin, B. Pannier, 2007, Journal of the American Society of Nephrology : JASN.

Aortic pulse wave velocity index and mortality in end-stage renal disease.

J. Blacher, M. Safar, G. London, 2003, Kidney international.

Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure

Raymond Vanholder, Patrick Rossignol, Carmine Zoccali, 2014, The Lancet.

Mechanism(s) of selective systolic blood pressure reduction after a low-dose combination of perindopril/indapamide in hypertensive subjects: comparison with atenolol.

M. Safar, G. London, M. O'Rourke, 2004, Journal of the American College of Cardiology.

Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure.

Chantal M Boulanger, G. London, A. Guérin, 2005, Journal of the American Society of Nephrology : JASN.